Background and aim: The present study was aimed at determining whether and to what extent a specific heart rate (HR) cutoff value allows to identify in obeses a more pronounced level of adrenergic overdrive. Methods and results: In 86 obese subjects aged 44.7 ± 0.9 (mean ± SEM) years and in 45 heathy lean controls of similar age we evaluated muscle sympathetic nerve traffic (MSNA, microneurography) and venous plasma norepinephrine (NE, HPLC assay), subdividing the subjects in 3 different groups according to their resting clinic and 24-h HR values (<70, 70–79 and 80–89 beats/minute). MSNA and plasma NE values detected in the three obese groups were almost superimposable each other, no significant difference between groups being observed. A similar behavior was observed when HR values were assessed during the 24-h Holter monitoring. In the group as a whole no significant relationship was detected between MSNA, plasma NE and clinic HR, this being the case also when 24-h HR replaced clinic HR in the correlation analysis. In contrast lean controls displayed a progressive significant increase in MSNA values form the group with clinic (and 24 Holter) values below 70 beats/minute to the ones with HR values between 70 and 79 and above 80 beats/minute. Conclusions: In the obese state measurement of resting HR may allow to provide some general information on the functional status of the adrenergic cardiovascular drive. When the information required, however, are more subtle the sensitivity of the approach appears to be reduced and HR cannot be regarded as a faithful sympathetic biomarker.

Seravalle, G., Facchetti, R., Cappellini, C., Annaloro, A., Gelfi, E., Grassi, G. (2022). Elevated heart rate as sympathetic biomarker in human obesity. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 32(10 (October 2022)), 2367-2374 [10.1016/j.numecd.2022.07.011].

Elevated heart rate as sympathetic biomarker in human obesity

Seravalle, G;Facchetti, R;Cappellini, C;Annaloro, A;Gelfi, E;Grassi, G
2022

Abstract

Background and aim: The present study was aimed at determining whether and to what extent a specific heart rate (HR) cutoff value allows to identify in obeses a more pronounced level of adrenergic overdrive. Methods and results: In 86 obese subjects aged 44.7 ± 0.9 (mean ± SEM) years and in 45 heathy lean controls of similar age we evaluated muscle sympathetic nerve traffic (MSNA, microneurography) and venous plasma norepinephrine (NE, HPLC assay), subdividing the subjects in 3 different groups according to their resting clinic and 24-h HR values (<70, 70–79 and 80–89 beats/minute). MSNA and plasma NE values detected in the three obese groups were almost superimposable each other, no significant difference between groups being observed. A similar behavior was observed when HR values were assessed during the 24-h Holter monitoring. In the group as a whole no significant relationship was detected between MSNA, plasma NE and clinic HR, this being the case also when 24-h HR replaced clinic HR in the correlation analysis. In contrast lean controls displayed a progressive significant increase in MSNA values form the group with clinic (and 24 Holter) values below 70 beats/minute to the ones with HR values between 70 and 79 and above 80 beats/minute. Conclusions: In the obese state measurement of resting HR may allow to provide some general information on the functional status of the adrenergic cardiovascular drive. When the information required, however, are more subtle the sensitivity of the approach appears to be reduced and HR cannot be regarded as a faithful sympathetic biomarker.
Articolo in rivista - Articolo scientifico
Body mass index; Heart rate; HOMA index; Obesity; Plasma norepinephrine; Sympathetic activity; Sympathetic nerve traffic;
English
2367
2374
8
Seravalle, G., Facchetti, R., Cappellini, C., Annaloro, A., Gelfi, E., Grassi, G. (2022). Elevated heart rate as sympathetic biomarker in human obesity. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 32(10 (October 2022)), 2367-2374 [10.1016/j.numecd.2022.07.011].
Seravalle, G; Facchetti, R; Cappellini, C; Annaloro, A; Gelfi, E; Grassi, G
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/392957
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact